Phase II Study of Gemcitabine + S-1 in Elderly Patients With Non-Small Cell Lung Cancer
Phase of Trial: Phase II
Latest Information Update: 10 May 2017
At a glance
- Drugs Gemcitabine (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 08 May 2008 New trial record.